Media Coverage
Back to Media CoverageGrowth, recognition, results—and an important partnership
One of the biggest milestones we anticipate for 2019 is the start of clinical trials for our lead candidate, SIG-001, in hemophilia A.
One of the biggest milestones we anticipate for 2019 is the start of clinical trials for our lead candidate, SIG-001, in hemophilia A.